aPTT Test: Normal Ranges, Prolonged & Shortened Results Exp…

aPTT

Coagulação

Última revisão: 7 de abril de 2026. Abordagem de fontes: contexto padrão de interpretação laboratorial, material médico de referência e orientações clínicas ou de saúde pública quando relevantes.

O que é aPTT?

The aPTT (activated partial thromboplastin time) is a coagulation screening test that measures how long it takes blood to form a clot through the intrinsic and common coagulation pathways. It evaluates the function of clotting factors XII, XI, IX, VIII, X, V, II (prothrombin), and I (fibrinogen). In the laboratory, a blood sample is mixed with a phospholipid reagent, a contact activator (such as kaolin, silica, or ellagic acid), and calcium chloride, and the time to clot formation is recorded in seconds.

The aPTT is one of the most widely ordered coagulation tests, used both for screening bleeding disorders and for monitoring anticoagulation therapy—particularly unfractionated heparin. It is especially sensitive to deficiencies in the intrinsic pathway factors (VIII, IX, XI, XII). When used alongside the prothrombin time (PT/INR), which evaluates the extrinsic pathway, the two tests together help localize which segment of the coagulation cascade is abnormal, guiding further diagnostic workup for bleeding or clotting disorders.

Por que isso importa

The aPTT is essential for evaluating the body's ability to form blood clots properly. A prolonged aPTT may indicate a bleeding disorder such as hemophilia A (factor VIII deficiency) or hemophilia B (factor IX deficiency), von Willebrand disease, or the presence of an inhibitor like a lupus anticoagulant. In clinical practice, aPTT is critical for monitoring patients on unfractionated heparin therapy—too little heparin increases clotting risk, while too much increases bleeding risk. The aPTT also serves as a preoperative screening tool to identify unsuspected coagulation abnormalities before surgery.

Faixas de referência normais

Grupo	Faixa	Unidade
Adults	25–35	seconds
Therapeutic heparin range	60–80	seconds
Newborns	31–54	seconds

As faixas de referência podem variar entre laboratórios. Sempre compare seus resultados com as faixas fornecidas pelo seu local de exame.

O que significam níveis altos de aPTT

Causas comuns

Hemophilia A (factor VIII deficiency) or B (factor IX deficiency)
von Willebrand disease
Unfractionated heparin therapy
Lupus anticoagulant (antiphospholipid syndrome)
Disseminated intravascular coagulation (DIC)
Liver disease (impaired clotting factor production)
Vitamin K deficiency (affects common pathway factors)
Factor XI or XII deficiency
Specific factor inhibitors (antibodies)

Possíveis sintomas

Easy bruising
Prolonged bleeding from cuts or dental procedures
Spontaneous nosebleeds (epistaxis)
Heavy menstrual bleeding
Joint bleeding (hemarthrosis)—classic in hemophilia
Blood in urine or stool
Excessive bleeding after surgery or trauma

O que fazer: A prolonged aPTT requires further investigation with a mixing study—mixing the patient's plasma with normal plasma to determine if the prolongation corrects (suggesting factor deficiency) or persists (suggesting an inhibitor). Based on results, specific factor levels, von Willebrand factor testing, or lupus anticoagulant testing may be ordered. If on heparin, the dose may need adjustment. Severe bleeding may require factor replacement, fresh frozen plasma, or cryoprecipitate.

O que significam níveis baixos de aPTT

Causas comuns

Extensive cancer (increased procoagulant activity)
Acute phase response (increased factor VIII as an acute phase reactant)
Early disseminated intravascular coagulation
Elevated factor VIII levels
Technical or sample issues

Possíveis sintomas

Usually no direct symptoms from shortened aPTT
May be associated with increased thrombotic risk in some contexts

O que fazer: A shortened aPTT is less commonly clinically significant but may indicate a hypercoagulable state. Evaluate for thrombotic risk factors, particularly if the patient has a history of blood clots. Check factor VIII levels, as elevated factor VIII is both an acute phase reactant and an independent thrombotic risk factor. Clinical correlation is essential.

Quando o exame de aPTT é recomendado?

As a preoperative coagulation screening test
When a bleeding disorder is suspected
To monitor unfractionated heparin therapy
When evaluating unexplained bruising or bleeding
As part of a thrombophilia workup
Before invasive procedures in patients with liver disease

Perguntas frequentes

The aPTT and PT/INR evaluate different portions of the coagulation cascade. The aPTT tests the intrinsic pathway (factors XII, XI, IX, VIII) and common pathway (X, V, II, fibrinogen), while the PT/INR tests the extrinsic pathway (factor VII) and common pathway. Prolonged aPTT with normal PT suggests an intrinsic pathway problem (e.g., hemophilia), while prolonged PT with normal aPTT suggests an extrinsic pathway issue (e.g., warfarin therapy or factor VII deficiency). If both are prolonged, the common pathway or multiple factors are affected.

Unfractionated heparin primarily enhances antithrombin activity against factors in the intrinsic and common pathways—the very factors that aPTT measures—making it the ideal monitoring tool. Warfarin, on the other hand, inhibits the vitamin K–dependent factors (II, VII, IX, X), and factor VII in the extrinsic pathway is affected earliest and most significantly, so the PT/INR is the appropriate monitoring test for warfarin. Low-molecular-weight heparins (like enoxaparin) do not reliably prolong the aPTT and are monitored with anti-Xa activity levels when monitoring is needed.

Yes, this is one of the most counterintuitive findings in hematology. A lupus anticoagulant prolongs the aPTT in the laboratory because it interferes with the phospholipid-dependent clotting reaction in the test tube. However, in the body, lupus anticoagulant is actually associated with an increased risk of thrombosis (blood clots), not bleeding. This is because the antibodies activate platelets and endothelial cells in vivo. A prolonged aPTT that does not correct with a mixing study, combined with a history of blood clots or pregnancy complications, raises suspicion for antiphospholipid syndrome.

Biomarcadores relacionados

aPTTActivated Partial Thromboplastin Time TP/INRTempo de Protrombina FibFibrinogênio

Referências e abordagem de revisão

As páginas do glossário de biomarcadores são explicações educativas e devem ser interpretadas junto com as faixas de referência e observações fornecidas pelo seu laboratório e pelo seu médico. Para conhecer nossos padrões editoriais e processo de revisão, veja nossa Política editorial e a nossa revisão de conteúdo.

Quer analisar seus níveis de aPTT?

Envie seus resultados de exames para receber uma análise instantânea com IA de todos os seus biomarcadores.

Enviar resultados de exames →

Aviso médico: Estas informações são apenas educativas e não substituem orientação, diagnóstico ou tratamento médico profissional. As faixas de referência podem variar entre laboratórios. Sempre converse com seu profissional de saúde sobre a interpretação dos seus resultados específicos.